Gabriele Calizzani1, Ivana Menichini2, Fabio Candura1, Monica Lanzoni3, Samantha Profili1, Maria Rita Tamburrini4, Antonio Fortino5, Stefania Vaglio6, Giuseppe Marano1, Giuseppina Facco1, Emily Oliovecchio7, Massimo Franchini8, Antonio Coppola9, Romano Arcieri10, Cinzia Bon11, Mario Saia12, Sabina Nuti13, Massimo Morfini14, Giancarlo M Liumbruno1, Giovanni Di Minno9, Giuliano Grazzini1. 1. National Blood Centre, National Institute of Health, Rome, Italy. 2. Italian Federation of Haemophilia Societies (FedEmo), Rome, Italy Necstep Studio Associato, Modena, Italy. 3. National Blood Centre, National Institute of Health, Rome, Italy IRCCS Ca' Granda Foundation Maggiore Policlinico Hospital, Milan, Italy. 4. Blood and Transplant Unit, Ministry of Health, Rome, Italy. 5. National Institute for Health, Migration and Poverty, Rome, Italy. 6. National Blood Centre, National Institute of Health, Rome, Italy Faculty of Medicine and Psychology, Sapienza University of Rome, Rome, Italy. 7. Department of Internal Medicine, University of Perugia, Perugia, Italy Italian Association of Haemophilia Centres (AICE), Florence, Italy. 8. Department of Transfusion Medicine and Hematology, Carlo Poma Hospital, Mantua, Italy Italian Association of Haemophilia Centres (AICE), Florence, Italy. 9. Regional Reference Centre for Coagulation Disorders, Federico II University Hospital, Naples, Italy Italian Association of Haemophilia Centres (AICE), Florence, Italy. 10. Italian Federation of Haemophilia Societies (FedEmo), Rome, Italy. 11. Veneto Region Health Authority, Venice, Italy. 12. Veneto Region Health Directorate, Venice, Italy. 13. Laboratorio Management e Sanità, Istituto di Management, Scuola Superiore Sant'Anna, Pisa, Italy. 14. Italian Association of Haemophilia Centres (AICE), Florence, Italy.
Abstract
INTRODUCTION: Due to the increase in life expectancy, patients with haemophilia and other inherited bleeding disorders are experiencing age-related comorbidities that present new challenges. In order to meet current and emerging needs, a model for healthcare pathways was developed through a project funded by the Italian Ministry of Health. The project aimed to prevent or reduce the social-health burden of the disease and its complications. MATERIAL AND METHODS: The National Blood Centre appointed a panel of experts comprising clinicians, patients, National and Regional Health Authority representatives. Following an analysis of the scientific and regulatory references, the panel drafted a technical proposal containing recommendations for Regional Health Authorities, which has been formally submitted to the Ministry of Health. Finally, a set of indicators to monitor haemophilia care provision has been defined. RESULTS: In the technical document, the panel of experts proposed the adoption of health policy recommendations summarised in areas, such as: multidisciplinary integrated approach for optimal healthcare provision; networking and protocols for emergency care; home therapy; registries/databases; replacement therapy supply and distribution; recruitment and training of experts in bleeding disorders. The recommendations became the content of proposal of agreement between the Government and the Regions. Monitoring and evaluation of haemophilia care through the set of established indicators was partially performed due to limited available data. CONCLUSIONS: The project provided recommendations for the clinical and organisational management of patient with haemophilia. A particular concern was given to those areas that play a critical role in the comorbidities and complications prevention. Recommendations are expected to harmonise healthcare care delivery across regional networks and building the foundation for the national haemophilia network.
INTRODUCTION: Due to the increase in life expectancy, patients with haemophilia and other inherited bleeding disorders are experiencing age-related comorbidities that present new challenges. In order to meet current and emerging needs, a model for healthcare pathways was developed through a project funded by the Italian Ministry of Health. The project aimed to prevent or reduce the social-health burden of the disease and its complications. MATERIAL AND METHODS: The National Blood Centre appointed a panel of experts comprising clinicians, patients, National and Regional Health Authority representatives. Following an analysis of the scientific and regulatory references, the panel drafted a technical proposal containing recommendations for Regional Health Authorities, which has been formally submitted to the Ministry of Health. Finally, a set of indicators to monitor haemophilia care provision has been defined. RESULTS: In the technical document, the panel of experts proposed the adoption of health policy recommendations summarised in areas, such as: multidisciplinary integrated approach for optimal healthcare provision; networking and protocols for emergency care; home therapy; registries/databases; replacement therapy supply and distribution; recruitment and training of experts in bleeding disorders. The recommendations became the content of proposal of agreement between the Government and the Regions. Monitoring and evaluation of haemophilia care through the set of established indicators was partially performed due to limited available data. CONCLUSIONS: The project provided recommendations for the clinical and organisational management of patient with haemophilia. A particular concern was given to those areas that play a critical role in the comorbidities and complications prevention. Recommendations are expected to harmonise healthcare care delivery across regional networks and building the foundation for the national haemophilia network.
Authors: J Astermark; C Negrier; C Hermans; P A Holme; R Klamroth; P Kotsi; P de Moerloose; J Pasi; A Rocino; M von Depka; J Windyga; C A Ludlam Journal: Haemophilia Date: 2009-01 Impact factor: 4.287
Authors: A Tagliaferri; G F Rivolta; A Iorio; E Oliovecchio; M E Mancuso; M Morfini; A Rocino; M G Mazzucconi; M Franchini; N Ciavarella; A Scaraggi; L Valdrè; G Tagariello; P Radossi; G Muleo; P G Iannaccaro; C Biasoli; D Vincenzi; M L Serino; S Linari; C Molinari; E Boeri; M La Pecorella; M T Carloni; E Santagostino; G Di Minno; A Coppola; A Rocino; E Zanon; L Spiezia; C Di Perna; M Marchesini; M Marcucci; A Dragani; S Macchi; P Albertini; M D'Incà; C Santoro; F Biondo; G Piseddu; G Rossetti; G Barillari; G Gandini; A C Giuffrida; G Castaman Journal: Haemophilia Date: 2010-02-09 Impact factor: 4.287
Authors: M Morfini; S Haya; G Tagariello; H Pollmann; M Quintana; B Siegmund; N Stieltjes; G Dolan; J Tusell Journal: Haemophilia Date: 2007-09 Impact factor: 4.287
Authors: B T Colvin; J Astermark; K Fischer; A Gringeri; R Lassila; W Schramm; A Thomas; J Ingerslev Journal: Haemophilia Date: 2008-01-30 Impact factor: 4.287